India Globalization Capital, Inc. (IGC)

$0.33

-0.00 (-0.60%)
Rating:
Recommendation:
Buy
Symbol IGC
Price $0.33
Beta 3.423
Volume Avg. 0.16M
Market Cap 18.394M
Shares () -
52 Week Range 0.28-1.16
1y Target Est -
DCF Unlevered IGC DCF ->
DCF Levered IGC LDCF ->
ROE -66.26% Strong Sell
ROA -69.65% Strong Sell
Operating Margin -
Debt / Equity 9.57% Neutral
P/E -1.32 Sell
P/B 0.94 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest IGC news


Mr. Ram Mukunda
Industrials
Conglomerates
American Stock Exchange

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.